A retrospective analysis in gastric cancer reveals that high Foxp3+ Treg infiltration in stages I–II is associated with higher five-year survival rates, contrasting with poorer outcomes in stages III–IV [255]. This evidence concerns the gene FOXP3 and gastric cancer.